Tatva Chintan Pharma Chem Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem Limited has submitted a disclosure report to the stock exchange under Regulation 10(6) of the SEBI Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011. This filing pertains to an acquisition that was made under an exemption provided in Regulation 10, which covers certain categories of share purchases that are exempt from the normal open offer requirements. No further details on the size of the acquisition, the parties involved, or the specific exemption relied upon are available from the headline alone.
This is a routine regulatory disclosure and typically does not have a direct material impact on the stock price. Shareholders should look for the detailed filing to understand whether the acquisition affects promoter or significant shareholder holdings.